Donate

Login

About Us
Members
CMT and You
CMT Kids
News & Events
Research
Health Professionals
Supporting Us
Contact

×

Press Release – Inside Information Pharnext Provides U.S. Regulatory Update on PLEODRUG™

2019.08.30_PXT3003_US_FDA_EN

Post navigation

CRISPR/Cas9 Treatment Can Improve Nerve Functioning in Mouse Model of CMT1A, Study Suggests

Pharnext Announces Encouraging Data from Open ‐ Label Phase 3 Extension Study of PXT3003

Connect with us

Last Updated: Tuesday 1st October, 2019

Contact
Privacy Policy
Terms & Conditions

CMT United Kingdom – Copyright ©2018 – All Rights Reserved
Registered charity number 1112370 – Company number 05574584

Built by Kaluna.

Login

Username *

Password *

Forgot password?

Continue

Register/Re-register

Having problems? Help me